Elizabeth Arden Unveils Premium-Priced Prevage Anti-Aging Treatment
This article was originally published in The Rose Sheet
Executive Summary
Elizabeth Arden is positioning its Prevage Anti-Aging Treatment as a revolutionary formula that "alters the chain reaction that can result in older looking skin," according to the firm
You may also be interested in...
Arden Net Sales Advance 7% In Q2 On Prevage, Fantasy Launches
Elizabeth Arden will emphasize Internet banner and print advertising in support of its Prevage anti-aging product, while stepping back from mediums like outdoor advertising, CEO Scott Beattie said during a Feb. 2 second quarter earnings call
Arden Net Sales Advance 7% In Q2 On Prevage, Fantasy Launches
Elizabeth Arden will emphasize Internet banner and print advertising in support of its Prevage anti-aging product, while stepping back from mediums like outdoor advertising, CEO Scott Beattie said during a Feb. 2 second quarter earnings call
Sales & Earnings In Brief
Elizabeth Arden: Prevage anti-aging treatment launch will be supported with print ads in 21 magazines over the next eight weeks, in addition to radio spots and Internet banners, company announces during Nov. 3 Q1 call. Prevage will be distributed in department and specialty stores including Saks Fifth Avenue, Nordstrom, Bloomingdale's, Henri Bendel and Bergdorf Goodman. The firm unveiled the line in September (1"The Rose Sheet" Aug. 15, 2005, p. 4). Arden's net sales increased 7.2% to $227.4 mil. for the first quarter (ended Sept. 30). Net income was $1.9 mil., excluding stock compensation expense, versus $4.8 mil. in the same period last year, due in part to weak consumer spending in Western Europe, Arden said. The firm has lowered full fiscal 2006 guidance, with sales expected to increase 6.5%-8% to $980 mil.-$995 mil., versus earlier expectations of $1 bil. - $1.02 bil. Earnings per diluted share for the year are anticipated to increase to $1.33-$1.39, excluding stock compensation expense...